dihexa safety concerns hgf c-met cancer risk Targeting Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease Targeting the HGF MET axis in cancer: therapeutic promise for natural compounds ScienceDirect HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



